| Literature DB >> 22675448 |
Surasri N Sahu1, Jada Lewis, Isha Patel, Serdar Bozdag, Jeong H Lee, Joseph E LeClerc, Hediye Nese Cinar.
Abstract
Vibrio cholerae cytolysin (VCC) is among the accessory V. cholerae virulence factors that may contribute to disease pathogenesis in humans. VCC, encoded by hlyA gene, belongs to the most common class of bacterial toxins, known as pore-forming toxins (PFTs). V. cholerae infects and kills Caenorhabditis elegans via cholerae toxin independent manner. VCC is required for the lethality, growth retardation and intestinal cell vacuolation during the infection. However, little is known about the host gene expression responses against VCC. To address this question we performed a microarray study in C. elegans exposed to V. cholerae strains with intact and deleted hlyA genes.Many of the VCC regulated genes identified, including C-type lectins, Prion-like (glutamine [Q]/asparagine [N]-rich)-domain containing genes, genes regulated by insulin/IGF-1-mediated signaling (IIS) pathway, were previously reported as mediators of innate immune response against other bacteria in C. elegans. Protective function of the subset of the genes up-regulated by VCC was confirmed using RNAi. By means of a machine learning algorithm called FastMEDUSA, we identified several putative VCC induced immune regulatory transcriptional factors and transcription factor binding motifs. Our results suggest that VCC is a major virulence factor, which induces a wide variety of immune response- related genes during V. cholerae infection in C. elegans.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22675448 PMCID: PMC3364981 DOI: 10.1371/journal.pone.0038200
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Genome-wide expression profile comparisons of the C. elegans genes regulated by pore forming toxins: V. cholerae hlyA, and B. thurigiensis Cry5B.
(A) A Venn diagram illustrating number of genes expressed in CVD109 versus CVD110, V. cholerae wild type versus DhlyA, and V. cholerae wild type versus CVD109 comparisons. (B) A Venn diagram illustrating number of genes expressed in CVD109 versus CVD110, V. cholerae wild type versus DhlyA, and Cry5B induction comparisons.
Genes induced over twofold following infection of C. elegans with hly(+) V. cholerae strains.
| Gene Name | Description | CVD109/CVD110 fold change | DhlyA/E7946 fold change | Reported Immune response function |
|
| C-type Lectin | 14.4 | 17.8 | Schulenburg et al, 2007 |
|
| C-type Lectin | 9.9 | 10.1 | Schulenburg et al, 2007 |
|
| hypothetical protein/Confirmed | 6.0 | 9.7 | Shapira et al, 2006 |
|
| Flavin-containing MonoOxygenase family | 2.3 | 8.9 | Irazoqui et al, 2008 |
|
| DAF-16/FOXO Controlled, germline Tumor affecting | 4.7 | 7.9 | |
|
| Collagen | 5.7 | 6.2 | |
|
| Collagen | 6.5 | 5.8 | |
|
| Groundhog (hedgehog-like family) | 3.6 | 5.6 | |
|
| hypothetical protein/Confirmed | 3.0 | 5.2 | |
|
| hypothetical protein/Confirmed | 3.9 | 4.9 | |
|
| hypothetical protein/Confirmed | 3.7 | 4.5 | Alper et al, 2007 |
|
| hypothetical protein/Partially confirmed | 3.2 | 4.2 | |
|
| Collagen | 3.6 | 4.1 | |
|
| hypothetical protein | 2.6 | 4.1 | |
|
| Prion-like-(Q/N-rich)-domain-bearing protein | 3.3 | 3.9 | Russell et al, 2008 |
|
| hypothetical protein/Confirmed | 2.5 | 3.7 | |
|
| Activated in Blocked Unfolded protein response | 3.2 | 3.6 | Russell et al, 2008 |
|
| hypothetical protein/Partially confirmed | 2.8 | 3.6 | |
|
| hypothetical protein/Confirmed | 2.3 | 3.5 | |
|
| hypothetical protein/Partially confirmed | 3.2 | 3.4 | |
|
| Activated in Blocked Unfolded protein response | 2.5 | 3.2 | Russell et al, 2008 |
|
| Tollish (Tolloid and BMP-1 family) | 2.1 | 3.1 | |
|
| Activated in Blocked Unfolded protein response | 2.9 | 3.1 | Russell et al, 2008 |
|
| Lipase related | 5.1 | 3.1 | |
|
| hypothetical protein/Partially confirmed | 2.2 | 3.0 | |
|
| hypothetical protein | 2.5 | 3.0 | |
|
| hypothetical protein/Confirmed | 2.2 | 2.9 | |
|
| Collagen | 3.0 | 2.8 | |
|
| Downstream Of DAF-16 (regulated by DAF-16) | 3.0 | 2.8 | Troemel et al, 2006Styer et al, 2008 |
|
| Tollish (Tolloid and BMP-1 family) | 2.0 | 2.8 | |
|
| C-type Lectin | 3.7 | 2.8 | Schulenburg et al, 2007 |
|
| hypothetical protein | 2.1 | 2.8 | |
|
| Glutamate-gated ChLoride channel | 2.1 | 2.7 | |
|
| hypothetical protein | 4.0 | 2.7 | |
|
| hypothetical protein | 2.4 | 2.7 | |
|
| Downstream Of DAF-16 (regulated by DAF-16) | 2.1 | 2.5 | Shapira et al, 2006Alper et al, 2007 |
|
| C-type Lectin | 2.8 | 2.5 | O'Rourke et al, 2006Schulenburg et al, 2007 |
|
| hypothetical protein/Confirmed | 2.4 | 2.5 | |
|
| Groundhog (hedgehog-like family) | 3.6 | 2.4 | |
|
| Nematode Specific Peptide family, group B | 2.5 | 2.4 | |
|
| hypothetical protein/Partially_confirmed | 2.1 | 2.4 | |
|
| C-type Lectin | 2.3 | 2.4 | Schulenburg et al, 2007 |
|
| Ligand-Gated ion Channel | 3.2 | 2.4 | |
|
| hypothetical protein/Confirmed | 2.5 | 2.3 | O'Rourke et al, 2006 |
|
| hypothetical protein/Partially_confirmed | 2.6 | 2.3 | |
|
| hypothetical protein/Partially_confirmed | 2.7 | 2.3 | |
|
| hypothetical protein/Confirmed | 2.0 | 2.3 | Troemel et al, 2006 |
|
| bacterial permeability-increasing protein | 2.0 | 2.2 | |
|
| hypothetical protein | 4.3 | 2.2 | |
|
| hypothetical protein/Partially_confirmed | 2.2 | 2.1 | |
|
| Nematode Specific Peptide family, group B | 2.3 | 2.1 | |
|
| hypothetical protein/Confirmed | 2.0 | 2.1 | |
|
| hypothetical protein/Confirmed | 2.3 | 2.1 | |
|
| hypothetical protein/Confirmed | 2.5 | 2.1 | |
|
| Muscle Positioning | 2.7 | 2.0 |
Only, genes induced over twofold in both CVD109/CVD110 and ΔhlyA/E7946 comparisons are listed.
Figure 2VCC- induced C. elegans genes mediate immune response.
(A) fmo-2, p = 0.0063 (B) clec-174, p = 0.0135 (C) dod-22, p = 0.0007 (D) dct-5, p = 0.0045 (E) B0024.4, p = 0.0001(F) C23G10.1, p = 0.0038 (G) col-54, p = 0.0001 (H) ttr-21, p = 0.7436, RNAi result in lethality. Expression of dod-22::GFP in worms fed on (I) V. cholerae wild type strain E7946, (J) DhlyA, and (K) OP50.
Prion-like (Q/N rich) domain protein genes regulated by hlyA.
| ORF NAME | GENE NAME | E7946/E7946Δ | CVD109/CVD110 |
|
|
| +3.9 | +3.35 |
|
|
| +3.64 | +3.21 |
|
|
| +3.27 | ND |
|
|
| +3.26 | +2.83 |
|
|
| +3.2 | ND |
|
|
| +3.11 | +2.99 |
|
|
| +1.98 | +3.46 |
|
|
| +1.9 | +2.12 |
|
|
| +1.87 | +1.85 |
|
|
| +1.81 | ND |
|
|
| +1.78 | +1.85 |
|
|
| +1.7 | +1.98 |
|
|
| +1.67 | +1.68 |
|
|
| +1.64 | ND |
|
|
| +1.54 | ND |
|
|
| +1.45 | ND |
|
|
| +1.4 | +1.73 |
|
|
| +1.38 | ND |
|
|
| +1.35 | ND |
|
|
| +1.34 | ND |
|
|
| +1.34 | ND |
|
|
| +1.31 | ND |
|
|
| +1.31 | ND |
|
|
| +1.28 | +2.82 |
|
|
| −1.2 | ND |
|
|
| −1.23 | −1.52 |
|
|
| −1.25 | ND |
|
|
| −1.33 | ND |
|
|
| −1.79 | ND |
|
|
| −2.46 | ND |
|
|
| −3.01 | ND |
ND: No Difference,(+) up-regulated, (−) down-regulated.
Figure 3RNAi of prion-like (Q/N rich) domain protein genes pqn-5 and pqn-54 causes increased lethality in C. elegans during V. cholerae infection.
(A) pqn-5 RNAi survival plot, p = 0.04 (B) pqn-54 RNAi survival plot, p = 0.02 (C) ced-1 RNAi survival plot p<0.0001.
Putative regulatory transcription factors identified using the Medusa program.
| Gene name | Description | GFP expression | ||
| CVD110 |
| |||
|
| ✓ | nuclear hormone receptor | Not known | |
|
| ✓ | ✓ | predicted Zn-finger protein | intestinal |
|
| ✓ | similar to vertebrate TEF proteins | Intestinal | |
|
| ✓ | ✓ | C2H2-type zn-finger and leucine zipper containing protein | Intestinal |
|
| ✓ | divergent nuclear receptor | Not known | |
|
| ✓ | ✓ | paired box transcription factor | Not known |
|
| ✓ | Zn-finger protein | Intestinal | |
|
| ✓ | DNA binding protein containing FLYWCH type Zn-finger domain | Not known | |
|
| ✓ | ✓ | nuclear hormone receptor | Not known |
|
| ✓ | Zn-finger protein, DHHC type | Not known | |
|
| ✓ | ✓ | Unnamed protein | Intestine only |
GFP expression data retrieved from WormBase.
Figure 4Lethality assays of the knock-downs of the FastMedusa identified immune response regulator transcription factors.
(A) pax-1(ok1949), p = 0.0013 and, (B) nhr-23, p = 0.0308 RNAi survival plots.
GO terms associated with binding motifs identified via FastMEDUSA.
| Motif Logo | Predictions | Top 5 specific predictions |
|
| 36 | MF |
| BP | ||
| MF RNA binding | ||
| CC spliceosomal complex | ||
| BP chromosome segregation | ||
|
| 21 | MF |
| BP | ||
| BP G-protein coupled receptor protein signaling pathway | ||
| BP | ||
| MF | ||
|
| 146 | CC extracellular space |
| CC integral to plasma membrane | ||
| MF calcium ion binding | ||
| MF hormone activity | ||
| BP cell adhesion | ||
|
| 52 | CC integral to plasma membrane |
| CC extracellular space | ||
| MF heme binding | ||
| BP excretion | ||
| CC keratin filament | ||
|
| 57 | MF |
| BP | ||
| BP intracellular protein transport | ||
| MF RNA binding | ||
| BP DNA repair | ||
|
| 408 | CC nucleolus |
| CC spliceosomal complex | ||
| BP rRNA processing | ||
| MF structural constituent of ribosome | ||
| MF translation regulator activity | ||
|
| 28 | MF |
| BP | ||
| BP G-protein coupled receptor protein signaling pathway | ||
| BP | ||
| BP | ||
|
| 114 | MF |
| BP | ||
| CC mitochondrial matrix | ||
| MF RNA binding | ||
| BP ncRNA metabolic process | ||
|
| 112 | BP regulation of striated muscle contraction |
| BP regulation of signal transduction | ||
| CC terminal button | ||
| BP cardiac muscle tissue morphogenesis | ||
| CC keratin filament | ||
|
| 64 | MF |
| BP | ||
| BP G-protein coupled receptor protein signaling pathway | ||
| BP | ||
| BP | ||
|
| 158 | BP nuclear mRNA splicing, via spliceosome |
| CC spliceosomal complex | ||
| CC nucleolus | ||
| BP rRNA processing | ||
| MF structural constituent of ribosome | ||
|
| 0 | |
|
| 34 | MF |
| BP | ||
| BP G-protein coupled receptor protein signaling pathway | ||
| BP | ||
| BP | ||
|
| 5 | MF |
| BP | ||
|
| 37 | MF |
| BP | ||
| BP G-protein coupled receptor protein signaling pathway | ||
| BP response to stimulus | ||
| MF | ||
|
| 71 | MF |
| BP | ||
| MF RNA binding | ||
| BP nuclear mRNA splicing, via spliceosome | ||
| MF structural constituent of ribosome | ||
|
| 94 | MF |
| BP | ||
| BP G-protein coupled receptor protein signaling pathway | ||
| CC extracellular space | ||
| BP | ||
|
| 70 | CC integral to plasma membrane |
| CC extracellular space | ||
| CC proteinaceous extracellular matrix | ||
| MF calcium ion binding | ||
| BP regulation of monooxygenase activity |